Notably, we found that the correlation between aPKCι and the expression of NF-κB, CD68, and CD206 is positive, and this biomarker combination is more effective than single biomarkers for predicting survival outcomes in patients with CCA. Here, NFKB1 is linked to cholangiocarcinoma.